Vaccines against RNA Viruses
RNA viruses cause animal, human, and zoonotic diseases that affect millions of individuals, as is being exemplified by the devastating ongoing epidemic of the recently identified SARS-Cov-2. For years vaccines have had an enormous impact on overcoming the global burden of diseases. Nowadays, a vast...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (166 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993546232504498 |
---|---|
ctrlnum |
(CKB)5400000000044451 (oapen)https://directory.doabooks.org/handle/20.500.12854/69449 (EXLCZ)995400000000044451 |
collection |
bib_alma |
record_format |
marc |
spelling |
Saiz, Juan Carlos edt Vaccines against RNA Viruses Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (166 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier RNA viruses cause animal, human, and zoonotic diseases that affect millions of individuals, as is being exemplified by the devastating ongoing epidemic of the recently identified SARS-Cov-2. For years vaccines have had an enormous impact on overcoming the global burden of diseases. Nowadays, a vast number of different approaches, from purified inactivated and live attenuated viruses, nucleic acid (DNA or RNA) based candidates, virus-like particles, subunit elements, and recombinant viruses are been employed to combat viruses. However, for many of them efficient vaccines are not yet available. This will probably change dramatically with the current Covid-19 pandemic, as a vast variety of vaccinology approaches are being tested against it, with hundreds of candidates under development, dozens of them already in clinical trials, a fact that is breaking records in vaccine development and implementation. This is becoming possible thanks to the enormous work carried out during years to have the bases for a quick response, even against unknown pathogens, in an impressive short time. Here, results obtained with different vaccine´s methodological approaches against human (HIV, HCV, HRV) animal (PRRSV, PEDV, FMDV, VHSV) and zoonotic (RVF, WNV), RNA viruses are presented by field experts. English Medicine bicssc artificial protein polyepitope B- and T-cell HIV-1 immunogen epitopes of broadly neutralizing HIV-1 antibodies peptide mimic of discontinuous epitope immunogenicity birds vaccines West Nile virus flavivirus herd immunity porcine epidemic diarrhea virus RNA interference processivity factor intestine epithelial cells N gene rotavirus nanoparticle vaccine gnotobiotic pigs FMDV peptide vaccine single dose amount pig VHSV non-virion (NV) transcriptome profiling rainbow trout immune pathways Rift Valley fever virus (RVFV) modified vaccinia Ankara (MVA) cellular response neutralizing antibodies Gn Gc glycoproteins passive serum:virus transfer hepatitis C virus neutralising antibodies animal models immune responses PRRSV Mosaic T-cell DNA vaccine VACV PRRS cross protection heterologous virus challenge 3-03943-623-6 3-03943-624-4 Saiz, Juan Carlos oth |
language |
English |
format |
eBook |
author2 |
Saiz, Juan Carlos |
author_facet |
Saiz, Juan Carlos |
author2_variant |
j c s jc jcs |
author2_role |
Sonstige |
title |
Vaccines against RNA Viruses |
spellingShingle |
Vaccines against RNA Viruses |
title_full |
Vaccines against RNA Viruses |
title_fullStr |
Vaccines against RNA Viruses |
title_full_unstemmed |
Vaccines against RNA Viruses |
title_auth |
Vaccines against RNA Viruses |
title_new |
Vaccines against RNA Viruses |
title_sort |
vaccines against rna viruses |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2020 |
physical |
1 electronic resource (166 p.) |
isbn |
3-03943-623-6 3-03943-624-4 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT saizjuancarlos vaccinesagainstrnaviruses |
status_str |
n |
ids_txt_mv |
(CKB)5400000000044451 (oapen)https://directory.doabooks.org/handle/20.500.12854/69449 (EXLCZ)995400000000044451 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Vaccines against RNA Viruses |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1787548726838951938 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03640nam-a2200781z--4500</leader><controlfield tag="001">993546232504498</controlfield><controlfield tag="005">20231214133249.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044451</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69449</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044451</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Saiz, Juan Carlos</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vaccines against RNA Viruses</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (166 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">RNA viruses cause animal, human, and zoonotic diseases that affect millions of individuals, as is being exemplified by the devastating ongoing epidemic of the recently identified SARS-Cov-2. For years vaccines have had an enormous impact on overcoming the global burden of diseases. Nowadays, a vast number of different approaches, from purified inactivated and live attenuated viruses, nucleic acid (DNA or RNA) based candidates, virus-like particles, subunit elements, and recombinant viruses are been employed to combat viruses. However, for many of them efficient vaccines are not yet available. This will probably change dramatically with the current Covid-19 pandemic, as a vast variety of vaccinology approaches are being tested against it, with hundreds of candidates under development, dozens of them already in clinical trials, a fact that is breaking records in vaccine development and implementation. This is becoming possible thanks to the enormous work carried out during years to have the bases for a quick response, even against unknown pathogens, in an impressive short time. Here, results obtained with different vaccine´s methodological approaches against human (HIV, HCV, HRV) animal (PRRSV, PEDV, FMDV, VHSV) and zoonotic (RVF, WNV), RNA viruses are presented by field experts.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">artificial protein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyepitope B- and T-cell HIV-1 immunogen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epitopes of broadly neutralizing HIV-1 antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptide mimic of discontinuous epitope</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunogenicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">birds</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">West Nile virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">flavivirus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">herd immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">porcine epidemic diarrhea virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RNA interference</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">processivity factor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intestine epithelial cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">N gene</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rotavirus nanoparticle vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gnotobiotic pigs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FMDV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptide vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">single dose</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">amount</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pig</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VHSV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-virion (NV)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">transcriptome profiling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rainbow trout</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune pathways</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Rift Valley fever virus (RVFV)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">modified vaccinia Ankara (MVA)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cellular response</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neutralizing antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Gn Gc glycoproteins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">passive serum:virus transfer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatitis C virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neutralising antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">animal models</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune responses</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PRRSV Mosaic T-cell DNA vaccine VACV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PRRS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cross protection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heterologous virus challenge</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-623-6</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-624-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saiz, Juan Carlos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:48:25 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338192340004498&Force_direct=true</subfield><subfield code="Z">5338192340004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338192340004498</subfield></datafield></record></collection> |